4.3. Antiviral Activity Assay

JA Julien Andreani
PJ Priscilla Jardot
MB Manon Boxberger
JM Joel Mosnier
MB Marion Le Bideau
ID Isabelle Duflot
IF Isabelle Fonta
CR Clara Rolland
HB Hervé Bogreau
BS Bernard La Scola
BP Bruno Pradines
request Request a Protocol
ask Ask a question
Favorite

Briefly, 96-well plates were prepared with 5.105 cells/mL of Vero E6 (200 µL per well), as previously described. Doxycycline and chloroquine concentrations were added 4 h before infection. Vero E Cells were infected with IHUMI-3 strain at an MOI of 0.25. After 48 h post-infection, the replication was estimated by RT-PCR using the Superscrit III platinum one step with Rox kit (Invitrogene) after extraction with the BIoExtract SuperBall kit (Biosellal, Dardilly, France). The primers used were previously described [69]. The percentage of inhibition of SARS-CoV-2 replication was estimated for each drug concentration as following: (mean CTdrug concentration − mean CTcontrol 0%)/(mean CTcontrol 100% − mean CTcontrol 0%) × 100. EC50 (median effective concentration) and EC90 (90% effective concentration) were calculated with the inhibitory sigmoid Emax model, which estimated the EC50 and EC90 through nonlinear regression by using a standard function of the R software (ICEstimator version 1.2). EC50 and EC90 values resulted in the mean of 10 different experimentations.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A